NCT06155396 2024-02-28A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical CancerRemeGen Co., Ltd.Phase 2 Recruiting116 enrolled